315 related articles for article (PubMed ID: 2058224)
1. [Genesis of fibronectin in ascites--detection of cellular and plasma fibronectin in portal and malignant ascites].
Rieder H; Ramadori G; Meyer zum Büschenfelde KH
Z Gastroenterol; 1991 Jan; 29(1):16-21. PubMed ID: 2058224
[TBL] [Abstract][Full Text] [Related]
2. [Immunological parameters in the differential diagnosis of ascites secondary to peritoneal carcinomatosis, hepatic cirrhosis, and congestive heart failure].
Roldan-Molina F; de Oliveira e Silva A; dos Santos TE; Genzini T; de Miranda MP; de Oliveira RM; Santo GC; D'Albuquerque LA
Arq Gastroenterol; 1992; 29(2):56-61. PubMed ID: 1284885
[TBL] [Abstract][Full Text] [Related]
3. Role of fibronectin in diagnosis of malignant ascites.
Sood A; Moudgil A; Sood N; Kharay AS; Kaushal S; Narang AP
J Assoc Physicians India; 1997 Apr; 45(4):283-5. PubMed ID: 12521085
[TBL] [Abstract][Full Text] [Related]
4. [Fibronectin in the ascitic fluid: its diagnostic significance].
Mal F; Nizard G; Labadie H; Trinchet JC; Garnier M; Beaugrand M
Gastroenterol Clin Biol; 1987 Oct; 11(10):639-42. PubMed ID: 2826281
[TBL] [Abstract][Full Text] [Related]
5. Ascites in the state of Qatar: aetiology and diagnostic value of ascitic fluid analysis.
Khan FY
Singapore Med J; 2007 May; 48(5):434-9. PubMed ID: 17453102
[TBL] [Abstract][Full Text] [Related]
6. The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis.
Khandwalla HE; Fasakin Y; El-Serag HB
Am J Gastroenterol; 2009 Jun; 104(6):1401-5. PubMed ID: 19491852
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the prediction of malignancy.
Colloredo Mels G; Bellati G; Auriemma L; Perani C; Leandro G; Vacca N; Pinna N; Alfieri G; Ideo G
Ital J Gastroenterol; 1991 May; 23(4):179-86. PubMed ID: 1661195
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic paracentesis. A two-step approach.
Sartori M; Andorno S; Gambaro M; Leone F; Molinari GL; Pontiroli L; Aglietta M
Ital J Gastroenterol; 1996; 28(2):81-5. PubMed ID: 8781999
[TBL] [Abstract][Full Text] [Related]
9. [Recent aspects in the diagnosis and therapy of ascites].
Gerbes AL
Z Gastroenterol; 1987 Oct; 25(10):677-82. PubMed ID: 3318185
[TBL] [Abstract][Full Text] [Related]
10. Ascitic fluid concentrations of fibronectin and cholesterol: comparison of differential diagnostic value with the conventional protein determination.
Gerbes AL; Xie YN; Mezger J; Jüngst D
Liver; 1990 Jun; 10(3):152-7. PubMed ID: 2385156
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.
Rana SV; Babu SG; Kocchar R
Med Sci Monit; 2005 Mar; 11(3):CR136-42. PubMed ID: 15735567
[TBL] [Abstract][Full Text] [Related]
12. Fibronectin concentration in ascites differentiates between malignant and nonmalignant ascites.
Schölmerich J; Volk BA; Köttgen E; Ehlers S; Gerok W
Gastroenterology; 1984 Nov; 87(5):1160-4. PubMed ID: 6479538
[TBL] [Abstract][Full Text] [Related]
13. Elevated ascitic fluid fibronectin concentration. A non-specific finding.
Runyon BA
J Hepatol; 1986; 3(2):219-22. PubMed ID: 3794302
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of serum-ascites albumin gradient].
Zhu XH; Liu B; Cheng ZY
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):278-80. PubMed ID: 14653090
[TBL] [Abstract][Full Text] [Related]
15. [The analysis of ascitic fluid].
González Maldonado JJ
Rev Gastroenterol Mex; 1993; 58(2):170-2. PubMed ID: 7747028
[TBL] [Abstract][Full Text] [Related]
16. Ascitic fluid analysis in peritoneal carcinomatosis: comparison of various biochemical tests with ascitic cirrhotics.
Lu CW; Wang SS; Lee SD; Tsai YT; Lee FY; Shiesh SC; Wu SL; Lu RH; Lo KJ
Zhonghua Yi Xue Za Zhi (Taipei); 1991 May; 47(5):350-6. PubMed ID: 1649678
[TBL] [Abstract][Full Text] [Related]
17. Serum-ascites albumin concentration gradient: a physiologic approach to the differential diagnosis of ascites.
Paré P; Talbot J; Hoefs JC
Gastroenterology; 1983 Aug; 85(2):240-4. PubMed ID: 6862152
[TBL] [Abstract][Full Text] [Related]
18. Value of ascitic fibronectin and cholesterol concentration in the differentiation between malignancy-related and non-malignant ascites.
Archimandritis A; Kapsalas D; Douvara M; Tjivras M; Tsirantonaki M; Fertakis A
Ann Med Interne (Paris); 1996; 147(3):145-50. PubMed ID: 8796090
[TBL] [Abstract][Full Text] [Related]
19. Utility of ascitic fluid analysis in patients with malignancy-related ascites.
Salerno F; Restelli B; Incerti P; Annoni G; Capozza L; Badalamenti S; Lampertico P; Mojana E; Moser P; Tommasini M
Scand J Gastroenterol; 1990 Mar; 25(3):251-6. PubMed ID: 1690913
[TBL] [Abstract][Full Text] [Related]
20. The value of serum-ascites albumin gradient for the determination of portal hypertension in the diagnosis of ascites.
Dittrich S; Yordi LM; de Mattos AA
Hepatogastroenterology; 2001; 48(37):166-8. PubMed ID: 11268957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]